Biomarker Opportunity Gaia Medical Institute focuses on saliva biomarkers for point-of-care diagnostics, presenting a clear sales angle for partnerships around non-invasive testing devices, sample collection devices, and lab instrumentation integrations that complement saliva-based assays.

Traumatic Brain Injury Focus With a pipeline including saliva tests for traumatic brain injury and sports concussion, there is potential to collaborate with sports organizations, medical groups, and rehabilitation clinics seeking rapid, accurate TBI diagnostics and monitoring solutions.

SMB-Scale Growth Company size (11-50 employees) and revenue in the $1M-$10M range indicate a growth-stage biotech partner open to co-development, contract research, pilot programs, and channel partnerships to scale commercialization.

Tech Enablement Utilizing cloud and web technologies (AWS, Google Cloud, Netlify, Cloudflare) plus modern web presence suggests receptiveness to integrated digital platforms, telemetry, and data-sharing solutions that enhance test workflow and data security.

Healthcare Niche Fit Positioned in Southern California biotech hub with a focus on diverse saliva-based diagnostics (heart failure, dehydration, chemotherapy-induced neuropathy, infectious diseases), offering cross-sell opportunities to clinics, hospitals, and research institutions seeking multiplexed respiratory and cardiovascular biomarkers.